celecoxib has been researched along with Graves Ophthalmopathy in 2 studies
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, AM | 1 |
| Yin, HY | 1 |
| Chen, A | 1 |
| Liu, YW | 1 |
| Chuang, MC | 1 |
| He, H | 1 |
| Tighe, S | 1 |
| Sheha, H | 1 |
| Liao, SL | 1 |
| Kuriyan, AE | 1 |
| Phipps, RP | 1 |
| O'Loughlin, CW | 1 |
| Feldon, SE | 1 |
2 other studies available for celecoxib and Graves Ophthalmopathy
| Article | Year |
|---|---|
Celecoxib and Pioglitazone as Potential Therapeutics for Regulating TGF-β-Induced Hyaluronan in Dysthyroid Myopathy.
Topics: Adult; Blotting, Western; Case-Control Studies; Celecoxib; Cells, Cultured; Cyclooxygenase 2 Inhibit | 2016 |
Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib.
Topics: Aged; Celecoxib; Color Perception; Cyclooxygenase 2 Inhibitors; Female; Graves Ophthalmopathy; Human | 2008 |